DOCS Stock Overview
Operates a cloud-based digital platform for medical professionals in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Doximity, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$57.83 |
| 52 Week High | US$61.75 |
| 52 Week Low | US$22.96 |
| Beta | 1.4 |
| 1 Month Change | 19.98% |
| 3 Month Change | 39.35% |
| 1 Year Change | 107.13% |
| 3 Year Change | 12.20% |
| 5 Year Change | n/a |
| Change since IPO | 9.11% |
Recent News & Updates
Doximity: Strong Fundamentals And Growth Potential Makes It Attractive
Dec 06Doximity (NYSE:DOCS) Knows How To Allocate Capital
Dec 01
Earnings Not Telling The Story For Doximity, Inc. (NYSE:DOCS) After Shares Rise 34%
Nov 13Recent updates
Doximity: Strong Fundamentals And Growth Potential Makes It Attractive
Dec 06Doximity (NYSE:DOCS) Knows How To Allocate Capital
Dec 01Earnings Not Telling The Story For Doximity, Inc. (NYSE:DOCS) After Shares Rise 34%
Nov 13Does This Valuation Of Doximity, Inc. (NYSE:DOCS) Imply Investors Are Overpaying?
Nov 02Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?
Oct 15Doximity: Downgrade To Hold On Valuation Concerns
Oct 03Here's Why Doximity (NYSE:DOCS) Has Caught The Eye Of Investors
Sep 23There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump
Aug 18Doximity (NYSE:DOCS) Looks To Prolong Its Impressive Returns
Aug 10Doximity Faces Slower Revenue Growth As R&D Costs May Rise
Jul 23Is Doximity, Inc. (NYSE:DOCS) Trading At A 23% Discount?
Jul 23At US$27.97, Is It Time To Put Doximity, Inc. (NYSE:DOCS) On Your Watch List?
Jul 01Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking
Jun 09Doximity Earnings: Better Than Expected, But Still Mixed Outlook (Rating Upgrade)
May 17Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal
May 04Doximity: Significant Upside Remains, But Not Until The Growth Story Returns
Apr 29With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For
Apr 16Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)
Mar 26Doximity: Rating Upgrade To Buy As Outlook Turns Positive
Feb 21We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit
Feb 15What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?
Feb 13Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan
Jan 16Doximity (NYSE:DOCS) May Have Issues Allocating Its Capital
Jan 04Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism
Nov 10Doximity: Adding Value Using AI But Faces Near-Term Risks
Nov 01Doximity: Rating Downgrade As Investors Shift Focus To The Near-Term Outlook
Aug 24Doximity Earnings: Too Many Problems, Sell
Aug 09Doximity: Continue To See Positive Upside From Current Stock Level
Jul 05Doximity: Digital Health Play With Strong Fundamentals
Jun 21Doximity: Good Business But Extremely Overvalued
Feb 18Doximity Q3 Earnings: Disappointing Results
Feb 10Shareholder Returns
| DOCS | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 10.9% | -0.002% | -2.4% |
| 1Y | 107.1% | 2.2% | 23.4% |
Return vs Industry: DOCS exceeded the US Healthcare Services industry which returned 1.9% over the past year.
Return vs Market: DOCS exceeded the US Market which returned 23.3% over the past year.
Price Volatility
| DOCS volatility | |
|---|---|
| DOCS Average Weekly Movement | 11.4% |
| Healthcare Services Industry Average Movement | 9.4% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: DOCS's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: DOCS's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 827 | Jeff Tangney | www.doximity.com |
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems.
Doximity, Inc. Fundamentals Summary
| DOCS fundamental statistics | |
|---|---|
| Market cap | US$10.80b |
| Earnings (TTM) | US$174.11m |
| Revenue (TTM) | US$516.85m |
62.0x
P/E Ratio20.9x
P/S RatioIs DOCS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DOCS income statement (TTM) | |
|---|---|
| Revenue | US$516.85m |
| Cost of Revenue | US$51.98m |
| Gross Profit | US$464.87m |
| Other Expenses | US$290.76m |
| Earnings | US$174.11m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.93 |
| Gross Margin | 89.94% |
| Net Profit Margin | 33.69% |
| Debt/Equity Ratio | 0% |
How did DOCS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:04 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Doximity, Inc. is covered by 25 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vikram Kesavabhotla | Baird |
| Nisala Weerasuriya | Berenberg |
| Allen Lutz | BofA Global Research |